Silver Book Fact

Projections of Significant Heart Valve Disease — Diagnosed & Undiagnosed — in the 65+ U.K. Population

D'Arcy J, Coffeey S, Loudon M, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. European Heart Journal. 2016; 34(47). https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehw229

Reference

Title
Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study
Publication
European Heart Journal
Publication Date
2016
Authors
D'Arcy J, Coffeey S, Loudon M, et al
Volume & Issue
Volume 34, Issue 47
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Economic Burden

Related Facts

  • SAS patient hospitalization costs
    Symptomatic aortic stenosis (SAS) patients who do not undergo treatment cost Medicare as much as $1.3 billion each year due to rehospitalization, prolonged stays, admissions to skilled nursing facilities, and…  
  • Five-year health care resource use in medically managed SAS patients
     
  • Survival rates of sSAS patients who do not undergo valve replacement
    Patients with severe symptomatic aortic stenosis (sSAS) who do not undergo valve replacement have survival rates as low as 50% at two years and 20% at 5 years after the…  
  • Low detection rates for AS
    Prevalence estimates for AS are likely low. A U.K. population screening found previously undetected HVD in 1 in 2 adults ages 65+.  
  • Prevalence of AS in Americans 75+
    An estimated 12.4%, or ~2.5 million people ages 75+ in North America, have AS.